Related Experiment Videos

Effect of erythromycin on Shigella infection of Caco-2 cells

Y Honma1, C Sasakawa, T Tsuji

  • 1Department of Microbiology, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan. yhonma@fujita-hu.ac.jp

Insights

Erythromycin (EM) at sub-inhibitory concentrations reduces Shigella flexneri invasion by affecting virulence plasmids. This macrolide antibiotic shows selective growth suppression of invasive bacteria, potentially explaining its clinical efficacy in shigellosis treatment.

Area of Science:

  • Microbiology
  • Pharmacology
  • Cell Biology

Background:

  • Shigella flexneri invasion of host cells is a key virulence factor in shigellosis.
  • Erythromycin (EM), a macrolide antibiotic, exhibits complex interactions with bacterial pathogens.
  • Sub-minimum inhibitory concentrations (subMIC) of antibiotics can have non-lethal effects on bacterial virulence.

Purpose of the Study:

  • To investigate the dose-dependent effect of Erythromycin (EM) on Shigella flexneri invasion of Caco-2 cells.
  • To determine the impact of EM on the invasion plasmid and virulence of S. flexneri.
  • To elucidate the mechanism underlying EM's effect on invasive S. flexneri.

Main Methods:

  • Treatment of S. flexneri LS13 with subMIC of EM.
  • Assessment of bacterial invasion efficiency in Caco-2 cells.
  • Congo red agar plate assay to evaluate invasion plasmid carriage.
  • Determination of minimum inhibitory concentrations (MIC) for virulent and mutant strains.

Main Results:

  • EM at subMIC significantly decreased the invasion efficiency of S. flexneri in Caco-2 cells.
  • EM treatment reduced the carrier rate of the invasion plasmid, which contains virulence genes.
  • Bacteria carrying the invasion plasmid were more susceptible to EM, with lower growth inhibition concentrations.
  • A mutant strain with an impaired type III secretion apparatus showed increased resistance to EM.

Conclusions:

  • Erythromycin selectively suppresses the growth of invasive S. flexneri, potentially via its type III secretion apparatus.
  • The reduction in invasion plasmid carriage and increased susceptibility of virulent strains contribute to EM's anti-invasive effect.
  • These findings suggest a novel mechanism for Erythromycin's clinical effectiveness in treating shigellosis.

Related Concept Videos